PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

PCI Clinical Services Gets Green Light to Begin Operations in Expansion of European Site

Leading international pharmaceutical outsourcing services provider PCI Clinical Services (PCI) has completed validation and received licensing of its newly expanded ...
Continue Reading →
News

Almac Group announces further expansion in support of clinical and commercial drug supplies at its European Campus in Dundalk, Ireland following successful HPRA Inspections

Almac Group, the global contract pharmaceutical development and manufacturing organisation, today confirmed the successful completion of Health Products Regulatory A...
Continue Reading →
News

BIA intervenes in Supreme Court case of critical importance to the bioscience sector

The UK Bioindustry Association (BIA) has been granted permission by the Supreme Court to intervene in its review of Warner-Lambert Company LLC v Generics (UK) Ltd an...
Continue Reading →
News

Avacta Group plc announces positive outcome of proof-of-concept study with Glythera and follow-on drug development partnership

Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that its initial study with Glythera Limited, the develo...
Continue Reading →
News

SYGNIS AG Installs Scalable Production Capability for Lightning-Link Antibody Conjugation Technology

SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard), the Group which includes Expedeon Holdings, Innova Biosciences, and C.B.S. Scientific Company, today...
Continue Reading →
News

Netherlands Cancer Institute grants exclusive license to Desktop Genetics for TIDE

Desktop Genetics Ltd (DTG), a biotech company globally recognised for its leadership in gene-editing bioinformatics, acquired exclusive worldwide licensing rights fo...
Continue Reading →
News

Meditraq launches to simplify serialisation data challenge

A new serialisation implementation partner has formed to assist the increasing number of companies needing to meet the data requirements of looming global regulation...
Continue Reading →
News

RDD 2018: Early Registration Deadline January 22

Now’s The Time to Plan to Participate, Register & Save.This readily accessible, major international symposium is where nasal and pulmonary product developers inn...
Continue Reading →
News

BMG LABTECH Australia celebrates 20 years of customer service excellence in the APAC region

This year, BMG LABTECH’s Australian office celebrates 20 years of innovation and steady growth. The office was established in January 1998 to support Australia and t...
Continue Reading →
News

Japanese pharma – no longer ‘lost in translation’

A New Year report from CPhI forecasts 2018 will be a transformative year for Japanese pharma as the market evolves towards growth in generics, biosimilars and increa...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026